TIME FOR A EUROPEAN ORPHAN DRUGS POLICY

被引：0
|
作者：
LEBLOND, D
机构：
来源：
EUROPEAN CHEMICAL NEWS | 1995年 / 63卷 / 1652期
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
Europe lags behind the US and Japan in the development of orphan drugs - defined as drugs for rare and tropical diseases - but a new report has proposals for putting it on a more equal footing. It suggests the establishment of a defined status for orphan drugs, to help this commercialisation.
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [41] Orphan drugs and orphan tests in the USA
    Thoene, JG
    [J]. COMMUNITY GENETICS, 2004, 7 (04) : 169 - 172
  • [42] STATUS OF ORPHAN DRUGS AND REIMBURSEMENT RECOMMENDATIONS AND DECISIONS IN ANALYSED EUROPEAN COUNTRIES
    Kawalec, P.
    Malinowski, K.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A598 - A599
  • [43] Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
    Devidas Menon
    Tania Stafinski
    Andrea Dunn
    Durhane Wong-Rieger
    [J]. The Patient - Patient-Centered Outcomes Research, 2015, 8 : 103 - 117
  • [44] Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
    Menon, Devidas
    Stafinski, Tania
    Dunn, Andrea
    Wong-Rieger, Durhane
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2015, 8 (01): : 103 - 117
  • [45] TRENDS OF ORPHAN DRUGS APROVALS OVER TIME IN THE UNITED STATES
    Thokagevistk, K.
    Dorey, J.
    Tavella, F.
    Remuzat, C.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A234 - A234
  • [46] Development of Orphan Drugs in Japan: Characteristics of Orphan Drugs Developed in Japan
    Makoto Shiragami
    Kiyohito Nakai
    [J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 839 - 846
  • [47] Development of orphan drugs in Japan: Characteristics of orphan drugs developed in Japan
    Shiragami, M
    Nakai, K
    [J]. DRUG INFORMATION JOURNAL, 2000, 34 (03): : 839 - 846
  • [48] A COMPARATIVE STUDY OF ACCESS TO ORPHAN DRUGS AND ORPHAN DRUGS REGULATIONS AND POLICIES
    Ounsirithupsakul, T.
    Samphansompoch, T.
    Sermsakulthai, T.
    Taychakhoonavudh, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S49 - S49
  • [49] Drugs trying to get the parents: There will be incentives for the European Scientific Community to develop research in the field of the orphan drugs
    Benzi, G
    Ceci, A
    [J]. PHARMACOLOGICAL RESEARCH, 1997, 35 (02) : 89 - 93
  • [50] ORPHAN DISEASES AND ORPHAN DRUGS - SCHEINBERG, WALSHE
    QURESHI, B
    [J]. JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1987, 107 (04): : 160 - 160
12345